Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Bloehdorn

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|August 14, 2025
Microangiopathic AnemiaMartin Bommer, Johannes Bloehdorn
Pathogens (Basel, Switzerland)|March 26, 2022
Salvage Therapy for Alveolar Echinococcosis-A Case SeriesSanne Burkert, Lynn Peters, Johannes Bloehdorn, et al.
Scientific Data|May 3, 2020
DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapyDeyan Yordanov Yosifov, Johannes Bloehdorn, Hartmut Döhner, et al.
The Journal of Experimental Medicine|October 24, 2012
Cellular origin and pathophysiology of chronic lymphocytic leukemiaMarc Seifert, Ludger Sellmann, Johannes Bloehdorn, et al.
Haematologica|April 21, 2019
Venetoclax resistance and acquired <i>BCL2</i> mutations in chronic lymphocytic leukemiaEugen Tausch, William Close, Anna Dolnik, et al.
Ejhaem|September 2, 2022
Targetable alterations in primary extranodal diffuse large B-cell lymphomaStephanie E Weissinger, Rucha Dugge, Miriam Disch, et al.
Neoplasia (New York, N.Y.)|December 14, 2020
U-RT1 - A new model for Richter transformationTeresa Schmid, Julia Maier, Melanie Martin, et al.
Neoplasia (New York, N.Y.)|February 21, 2026
Corrigendum to "U-RT1 - A new model for Richter transformation" [Neoplasia Volume 23, Issue 1, January 2021, Pages 140-148]Teresa Schmid, Julia Maier, Melanie Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemiaAlexander Kröber, Johannes Bloehdorn, Sebastian Hafner, et al.
Hemasphere|June 9, 2026
Lamin B1 safeguards the B cell genome and shapes lymphoma outcomeFilip Filipsky, Katarina B Chapman, Johannes Bloehdorn, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|August 14, 2025
Microangiopathic AnemiaMartin Bommer, Johannes Bloehdorn
Pathogens (Basel, Switzerland)|March 26, 2022
Salvage Therapy for Alveolar Echinococcosis-A Case SeriesSanne Burkert, Lynn Peters, Johannes Bloehdorn, et al.
Scientific Data|May 3, 2020
DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapyDeyan Yordanov Yosifov, Johannes Bloehdorn, Hartmut Döhner, et al.
The Journal of Experimental Medicine|October 24, 2012
Cellular origin and pathophysiology of chronic lymphocytic leukemiaMarc Seifert, Ludger Sellmann, Johannes Bloehdorn, et al.
Haematologica|April 21, 2019
Venetoclax resistance and acquired <i>BCL2</i> mutations in chronic lymphocytic leukemiaEugen Tausch, William Close, Anna Dolnik, et al.
Ejhaem|September 2, 2022
Targetable alterations in primary extranodal diffuse large B-cell lymphomaStephanie E Weissinger, Rucha Dugge, Miriam Disch, et al.
Neoplasia (New York, N.Y.)|December 14, 2020
U-RT1 - A new model for Richter transformationTeresa Schmid, Julia Maier, Melanie Martin, et al.
Neoplasia (New York, N.Y.)|February 21, 2026
Corrigendum to "U-RT1 - A new model for Richter transformation" [Neoplasia Volume 23, Issue 1, January 2021, Pages 140-148]Teresa Schmid, Julia Maier, Melanie Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemiaAlexander Kröber, Johannes Bloehdorn, Sebastian Hafner, et al.
Hemasphere|June 9, 2026
Lamin B1 safeguards the B cell genome and shapes lymphoma outcomeFilip Filipsky, Katarina B Chapman, Johannes Bloehdorn, et al.
Pageof 4